Product category:
Nucleic acid sequencing and synthesis
News Release from: Bioo Scientific | Subject: MaxSuppressor In Vivo RNA-Lancer II
Edited by the Laboratorytalk Editorial
Team on 24 July 2008
Second generation in vivo RNA delivery
In response to the growing need for high quality RNAi agent delivery mediums, Bioo Scientific presents MaxSuppressor In Vivo RNA-Lancer II
After extensive animal validation testing, we have identified a new in vivo delivery vehicle that has demonstrated significant value for gene knockdown in mice and rats MaxSuppressor In Vivo RNA-Lancer II (catalogue #3410-01) has drastically outperformed all other delivery agents tested
MaxSuppressorT In Vivo RNA-Lancer II uses a set of neutral hydrophobic molecules to encapsulate and deliver RNAi agents into tissues achieving maximal gene reduction with minimal amounts of RNAi agent.
This patent-pending formulation has utility for in vivo target validation and therapeutic agent development.
The procedure takes about one hour and can be performed in any laboratory setting.
• Bioo Scientific: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
